Page last updated: 2024-12-10
methyldithiocarbazate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
methyldithiocarbazate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3034069 |
SCHEMBL ID | 10117732 |
SCHEMBL ID | 1229894 |
MeSH ID | M0066670 |
Synonyms (27)
Synonym |
---|
nsc4423 |
nsc-4423 |
s-methyl dithiocarbazate |
5397-03-5 |
dithiocarbazic acid methyl ester |
methyl hydrazinecarbodithioate |
hydrazinecarbodithioic acid, methyl ester |
methyl dithiocarbazate |
carbazic acid, dithio-, methyl ester |
methyldithiocarbazate |
methyl n-aminocarbamodithioate |
AKOS006220764 |
nsc 4423 |
ai3-22502 |
hydrazinecarbodithioic acid methyl ester |
SCHEMBL10117732 |
DTXSID3063835 |
SCHEMBL1229894 |
GS-1932 |
{[(methylsulfanyl)methanethioyl]amino}amine |
mfcd00463356 |
methylhydrazinecarbodithioate |
A856889 |
EN300-43242 |
R2L2YRR7MP |
([(methylsulfanyl)methanethioyl]amino)amine |
F71622 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |